Clinical Trial of Bile Etiology ,Proteomics and Metabonomics of Malignant Biliary Obstruction

• Conditions: Malignant Biliary Obstruction

• Registration Number: NCT01073514
• Lead Sponsor: Tianjin Medical University Cancer Institute and Hospital

Brief Summary

To investigate bile culture and susceptibility test in patients with malignant biliary obstruction (MBO) or relation between bile, portal vein or vein culture and biliary infection. Also to get the information of bile metabonomics to find potential tumor marker .Culture of the organism is recognized as the "gold standard" for diagnosis of infection. Our research may be one of the first research on culture and susceptibility test in patients with MBO. The results of the trial research will be benefit to experiential therapy of MBO with biliary infection and diagnosis of MBO.

Detailed Description

We will obtain bile sample for culture and susceptibility ,proteomics metabonomics test after PTBD. Also get the blood and urine samples.

Study Timeline

• Study Start: 2009-12
• Status Verified: 2010-02
• Study First Submitted: 2010-02-21
• Study First Submitted QC: 2010-02-22
• Study First Posted: 2010-02-23
• Last Update Submitted: 2015-12-21
• Last Update Posted: 2015-12-22
• Primary Completion: 2016-11
• Study Completion: 2016-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

• Those with MBO who can receive Percutaneous Transhepatic Biliary Drainage(PTBD)

Exclusion Criteria

• Those with MBO who cannot receive Percutaneous Transhepatic Biliary Drainage(PTBD)

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Tianjin Medical University Cancer Institude and Hospital; 🇨🇳 Tianjin, Tianjin, China